A US clinical research company has announced a multi-million pound investment into its Livingston campus, creating 156 new jobs.
Q2 Solutions received a £3.8m Scottish Enterprise grant to help create a new “centre of excellence” for flow cytometry and genomics testing and analysis.
The investment will create new skilled jobs during the next three years, letting the company offer an increased range of services to clients, which include a range of pharmaceutical companies.
The multi-million-pound research and development project will help anchor Q2 Solutions’ operations in Scotland.
The new project will coincide with its ongoing £17m infrastructure expansion project at the campus, where the company already employs more than 950 people.
Economy Secretary Kate Forbes said: “Inward investment has a huge role to play in Scotland’s economic transformation – our skilled workforce, research facilities and supportive investment culture are highly attractive to foreign companies.”
Elaine Lowey, Q2 Solutions’ general manager for Europe, the Middle East and Africa, said: “Expanding our European operations in key technical areas supporting the development of new precision medications adds significant value to our global pharmaceutical and biotechnology clients.
“We are delighted to be working with Scottish Enterprise in this venture and look forward to the job creation this will bring in our new state-of-the-art facility.”
Don’t miss the latest headlines with our twice-daily newsletter – sign up here for free.
